Wong R, Jang J, Wong L, Kim J, Rojnuckarin P, Goh Y
Int J Mol Sci. 2024; 25(22).
PMID: 39596227
PMC: 11594386.
DOI: 10.3390/ijms252212160.
Lewis S
J R Coll Physicians Lond. 2019; 3(3):253-264.
PMID: 30667717
PMC: 5367124.
Pitney W
J R Coll Physicians Lond. 2019; 3(3):223-229.
PMID: 30667711
PMC: 5367118.
Mastellos D, Reis E, Yancopoulou D, Risitano A, Lambris J
Semin Hematol. 2018; 55(3):167-175.
PMID: 30032754
PMC: 6060635.
DOI: 10.1053/j.seminhematol.2018.02.002.
Kumar R, Dutta S, Kumar H, Lazar A, Sashindran V
Med J Armed Forces India. 2017; 50(1):27-30.
PMID: 28769156
PMC: 5529684.
DOI: 10.1016/S0377-1237(17)31033-X.
Successful Treatment of Ascites using a Denver Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome.
Kogiso T, Hashimoto E, Ito T, Hara T, Ikarashi Y, Kodama K
Intern Med. 2016; 55(20):2957-2963.
PMID: 27746432
PMC: 5109562.
DOI: 10.2169/internalmedicine.55.7087.
Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria.
Luzzatto L
F1000Res. 2016; 5.
PMID: 26962442
PMC: 4765720.
DOI: 10.12688/f1000research.7288.1.
Paroxysmal nocturnal hemoglobinuria induced by the occurrence of BCR-ABL in a PIGA mutant hematopoietic progenitor cell.
Tominaga R, Katagiri T, Kataoka K, Wee R, Maeda A, Gomyo H
Leukemia. 2015; 30(5):1208-10.
PMID: 26437783
DOI: 10.1038/leu.2015.268.
Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.
DeZern A, Brodsky R
Hematol Oncol Clin North Am. 2015; 29(3):479-94.
PMID: 26043387
PMC: 4695989.
DOI: 10.1016/j.hoc.2015.01.005.
Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria.
Olutogun T, Cutini I, Notaro R, Luzzatto L
Blood Transfus. 2015; 13(3):363-9.
PMID: 25761313
PMC: 4614287.
DOI: 10.2450/2015.0249-14.
Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going.
Risitano A
Transl Med UniSa. 2014; 8:43-52.
PMID: 24778997
PMC: 4000462.
A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
Raza A, Ravandi F, Rastogi A, Bubis J, Lim S, Weitz I
Cytometry B Clin Cytom. 2013; 86(3):175-82.
PMID: 24227693
PMC: 5594745.
DOI: 10.1002/cyto.b.21139.
Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial.
Kanakura Y, Ohyashiki K, Shichishima T, Okamoto S, Ando K, Ninomiya H
Int J Hematol. 2013; 98(4):406-16.
PMID: 23934275
DOI: 10.1007/s12185-013-1404-y.
Low concentration of serum haptoglobin has impact on understanding complex pathophysiology in patients with acquired bone marrow failure syndromes.
Shichishima T, Ikeda K, Takahashi N, Kameoka J, Tajima K, Murai K
Int J Hematol. 2010; 91(4):602-10.
PMID: 20376581
DOI: 10.1007/s12185-010-0559-z.
New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
Kawaguchi T, Nakakuma H
Int J Hematol. 2007; 86(1):27-32.
PMID: 17675263
DOI: 10.1532/IJH97.07029.
Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.
Shichishima T, Noji H
Int J Hematol. 2006; 84(2):97-103.
PMID: 16926129
DOI: 10.1532/IJH97.06083.
Paroxysmal nocturnal hemoglobinuria.
Omine M, Kinoshita T, Nakakuma H, Maciejewski J, Parker C, Socie G
Int J Hematol. 2006; 82(5):417-21.
PMID: 16533745
DOI: 10.1532/IJH97.05140.
Diagnosis and management of paroxysmal nocturnal hemoglobinuria.
Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R
Blood. 2005; 106(12):3699-709.
PMID: 16051736
PMC: 1895106.
DOI: 10.1182/blood-2005-04-1717.
Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems.
Rosse W, Nishimura J
Int J Hematol. 2003; 77(2):113-20.
PMID: 12627845
DOI: 10.1007/BF02983209.
Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Kinoshita T, Inoue N
Int J Hematol. 2002; 75(2):117-22.
PMID: 11939256
DOI: 10.1007/BF02982015.
